Dihomo gamma linolenic acid - first generation - DS Biopharma

Drug Profile

Dihomo gamma linolenic acid - first generation - DS Biopharma

Alternative Names: 8,11,14-eicosatrienoic-acid; all-cis-8,11,14-eicosatrienoic-acid; Bishomo-gamma-linolenic acid; DGLA; DHLA; Dihomogammalinolenic-acid; DS 107E; DS-107G; DS-107J; DS107; Gamma-homolinolenic-acid; Homo-gamma-linolenic-acid; RO-12-1989

Latest Information Update: 11 Oct 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dignity Sciences
  • Developer DS Biopharma
  • Class Anti-inflammatories; Antiacnes; Eicosanoids; Omega-6 fatty acids; Skin disorder therapies; Small molecules
  • Mechanism of Action Interleukin 10 inhibitors; Tumour necrosis factor alpha inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Acne vulgaris; Atopic dermatitis; Pruritus
  • No development reported Radiation-induced skin damage; Wounds

Most Recent Events

  • 03 Oct 2018 Adverse events and efficacy data from the phase IIb ADvantage trial in Atopic dermatitis released by DS Biopharma
  • 28 Sep 2018 No recent reports of development identified for preclinical development in Radiation-induced-skin-damage(Prevention) in Ireland (Topical)
  • 28 Sep 2018 No recent reports of development identified for preclinical development in Wounds in Ireland (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top